Analyst Ratings for Actuate Therapeutics (ACTU)
ACTU Rating Summary
ACTU Price Target Summary
- Highest: $35.00 (Lucid Capital Markets)
- Lowest: $8.00 (B.Riley)
- Average: $20.75
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$20.75 (+927.2%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$20.75 (+927.2%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/26/2025 | B.Riley » Updated 4/15/2026 |
Mayank Mamtani | New Coverage | Buy (N/A) |
8.00 (20.00) |
8.36 (2.02) |
-75.84% | Details |
| 4/22/2025 | Craig-Hallum » Updated 11/14/2025 |
Albert Lowe | New Coverage | Buy (N/A) |
25.00 (32.00) |
8.37 (2.02) |
-75.87% | Details |
 |
||||||||
